Mirae Asset Global ETFs Holdings’s Jade Biosciences JBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$210K Sell
14,961
-6,559
-30% -$95K ﹤0.01% 2337
2025
Q4
$332K Buy
21,520
+6,298
+41% +$73.9K ﹤0.01% 2106
2025
Q3
$131K Sell
15,222
-2,535
-14% -$20.7K ﹤0.01% 2543
2025
Q2
$177K Buy
17,757
+17,527
+7,620% +$597K ﹤0.01% 2342
2025
Q1
$20.2K Buy
230
+9
+4% +$791 ﹤0.01% 2981
2024
Q4
$20.5K Buy
221
+8
+4% +$689 ﹤0.01% 3004
2024
Q3
$15.5K Buy
213
+74
+53% +$4.77K ﹤0.01% 3024
2024
Q2
$8.1K Buy
+139
New +$92.2K ﹤0.01% 2968

Other funds holding JBIO

Mirae Asset Global ETFs Holdings's JBIO Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Jade Biosciences (JBIO) stake by 30% in Q1 2026, selling an estimated $95K and leaving 14,961 shares worth $210K. The position accounts for ﹤0.01% of the portfolio, ranked #2337.

Mirae Asset Global ETFs Holdings first reported a position in JBIO in Q2 2024 and has held it in 8 quarters since. The position peaked at $332K in Q4 2025. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 14,961 shares of Jade Biosciences worth $210K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings sold 6,559 Jade Biosciences shares in Q1 2026, an estimated $95K.
  • Jade Biosciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2337 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Jade Biosciences in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Jade Biosciences position peaked at $332K in Q4 2025.
  • 120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.